You are here

Approvals, Launches, and New Indications

First Oral Drug Increases Activity of the Body’s Deficient Enzyme
Venous Thromboembolism and Other Risks to Be Evaluated in Postmarketing Studies
Radiation Exposure Remains a Risk
The move is considered part of the antiterrorism effort.
Epidiolex is indicated for rare, severe forms of epilepsy
Patients as young as 7 years of age may now use the device for their type-1 diabetes
Sensor alerts adults with diabetes of high or low glucose levels via smartphone or tablet
However, patent dispute will delay one launch